- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €328.7m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.60
7D
-3.0%
1Y
-27.9%
MPH Health Care
Market Cap: €102.3m
An investment company, engages in the healthcare business in Germany.
93M1
€23.90
7D
-0.8%
1Y
37.4%
Novogenia
Market Cap: €71.4m
Manufactures and sells personalized health products in global markets.
7V0
€5.95
7D
-11.2%
1Y
-9.8%
Cantourage Group
Market Cap: €69.6m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.58
7D
-2.4%
1Y
35.4%